Promomed Group held its third town hall

Promomed Group held its third, already traditional town-hall meeting of the team with the management, where each employee could ask their questions about the strategy and sustainability of the business, personnel policy, the development of new drugs, and much more.

"We are not stopping supplies, we are not stopping production, we are continuing development, we are working even harder," he opened the meeting with this main thesis. Peter Bely, Chairman of the Board of Directors of Promomed Group. "In a situation of economic crisis, we have clear priorities. Not only are we not stopping, we intend to do more this year and in the following years than we had planned during the normal course of events," he added.

Maxim Smagin, General Director of Promomed, and Executive Director of Biochemist JSC (part of Promomed Group of Companies) answered questions from employees in the studio Dmitry Zemskov, Director of New Products Kira Zaslavskaya and HR Director Yuri Troyankin. Ekaterina Kumanina, Director of Corporate Communications, moderated the town hall.

The Town Hall studio was set up in Saransk at the Biochemist plant, where most of the group's employees are located.

The speakers answered questions about a new drug to combat the effects of COVID-19, the development of the company's cancer portfolio, the registration of new drugs, the hiring of employees, and much more, including anti-crisis measures taken by the company.

"We need a startup atmosphere now, so that any idea, any lively movement that appears to us, comes to the leadership as quickly as possible. There are no levels and no subordinates: We definitely need to hear each other now," he summed up the meeting. Peter the White.